Shandong Xinhua Pharmaceutical Company Limited Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Company Limited cash flow-to-debt ratio. Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of €56.11 Million could theoretically repay 0% of its total liabilities (€3.22 Billion) in one year. Check Shandong Xinhua Pharmaceutical Company L (XIN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Cash flow-to-debt ratio of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Check Shandong Xinhua Pharmaceutical Company L earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Shandong Xinhua Pharmaceutical Company Limited Cash Flow-to-Debt Ratio by Year (2013–2025)
Shandong Xinhua Pharmaceutical Company Limited cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Company Limited. For the full cash flow conversion analysis, see XIN cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €533.73 Million | €3.73 Billion | ▲ +48.0% |
| 2024 | 0.10x | €367.61 Million | €3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | €265.28 Million | €3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | €758.24 Million | €3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | €259.12 Million | €3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | €420.19 Million | €3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | €348.27 Million | €3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | €323.91 Million | €3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | €389.97 Million | €2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | €439.35 Million | €2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | €348.64 Million | €2.51 Billion | ▼ -6.4% |
| 2014 | 0.15x | €346.34 Million | €2.33 Billion | ▲ +200.6% |
| 2013 | 0.05x | €104.99 Million | €2.13 Billion | — |